Market Cap: $1.05B
JI
Janux Therapeutics, Inc.
JANX
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.05B
Janux Therapeutics Elevates Leadership with Appointment of Dr. Zachariah McIver as Chief Medical Officer Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering im…
Clear Street Expands Healthcare Research Focus, Enhancing Biotechnology Insights Clear Street, a cloud-native financial technology firm, broadens its equity research capabilities by launching a new fo…
Janux Therapeutics Secures Funding to Propel Immunotherapy Development Janux Therapeutics, Inc., a prominent player in the clinical-stage biopharmaceutical sector, successfully closes a significant pu…
Janux Therapeutics Secures Funding to Propel Immunotherapy Development Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company renowned for its innovative immunotherapy platforms, has ann…
Janux Therapeutics Expands Clinical Development with Strategic Public Offering Janux Therapeutics, a clinical-stage biopharmaceutical company, announces a significant advancement in its funding strate…
Janux Therapeutics Advances Immunotherapy with Promising Results for JANX007 in Prostate Cancer Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in immunotherapy, reve…
Janux Therapeutics Reports Promising Clinical Data for JANX007 in Prostate Cancer Treatment Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in immunotherapy, unveils…
Janux Therapeutics Advances Immunotherapy Development Amid Rising Expenses Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company, emphasizes its commitment to pioneering novel immunothe…